InsiderClue
Insiders · Profile

Clark Eliana

EVP, Chief Technical Officer at Intellia Therapeutics. Filing since 1 Jul 2022. CIK 0001914448

Company
Date
Role
Action
Shares
Amount
Of holding
NTLA Intellia Therapeutics, Inc.
2 Mar 2026
EVP, Chief Technical Officer
Sold at will
607
$8.36K
0.6%
NTLA Intellia Therapeutics, Inc.
5 Jan 2026
EVP, Chief Technical Officer
Sold at will
9,515
$87.63K
9.8%
NTLA Intellia Therapeutics, Inc.
1 Jul 2025
EVP, Chief Technical Officer
Sold at will
1,022
$10.04K
1.1%
NTLA Intellia Therapeutics, Inc.
4 Mar 2025
EVP, Chief Technical Officer
Sold at will
679
$6.10K
0.7%
NTLA Intellia Therapeutics, Inc.
3 Jan 2025
EVP, Chief Technical Officer
Sold at will
7,422
$90.40K
10.4%
NTLA Intellia Therapeutics, Inc.
2 Jan 2025
EVP, Chief Technical Officer
Sold at will
556
$6.69K
0.8%
NTLA Intellia Therapeutics, Inc.
1 Jul 2024
EVP, Chief Technical Officer
Sold at will
405
$9.29K
0.6%
NTLA Intellia Therapeutics, Inc.
4 Mar 2024
EVP, Chief Technical Officer
Sold at will
605
$19.96K
0.8%
NTLA Intellia Therapeutics, Inc.
3 Jan 2024
EVP, Chief Technical Officer
Sold at will
4,608
$135.95K
10.1%
NTLA Intellia Therapeutics, Inc.
3 Jul 2023
EVP, Chief Technical Officer
Sold at will
360
$14.58K
0.8%
NTLA Intellia Therapeutics, Inc.
20 Jun 2023
EVP, Chief Technical Officer
Sold on a plan
5,000
$225.00K
10.0%
NTLA Intellia Therapeutics, Inc.
4 Jan 2023
EVP, Chief Technical Officer
Sold, plan not stated
1,692
$62.96K
10.5%
NTLA Intellia Therapeutics, Inc.
3 Jan 2023
EVP, Chief Technical Officer
Sold, plan not stated
231
$7.96K
1.4%
NTLA Intellia Therapeutics, Inc.
1 Jul 2022
EVP, Chief Technical Officer
Sold, plan not stated
105
$5.43K
0.6%
14 decisions on file.